News & Analysis as of

Data Protection Ministry of Health

Smart & Biggar

Federal Court of Appeal dismisses appeal of SPRAVATO “innovative drug” decision

Smart & Biggar on

On November 10, 2021, the Minister of Health refused to reassess its decision that Janssen’s esketamine hydrochloride product (SPRAVATO) was not an “innovative drug” and therefore not entitled to data protection. As...more

Latham & Watkins LLP

New UAE Law Regulates Healthcare Data

Latham & Watkins LLP on

Healthcare entities should assess whether Federal Law No. 2 of 2019 applies to their practices and plan for compliance. On 6 February 2019, the President of the United Arab Emirates (UAE) in conjunction with the UAE...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide